Nanni Huser
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer 5
- DNA Repair Mechanisms 2
- RNA modifications and cancer 2
- Oncology top 10%
- Cancer-related Molecular Pathways 4
- HER2/EGFR in Cancer Research 2
- Genetics top 10%
-
- Acute Myeloid Leukemia Research 2
-
- Advanced Breast Cancer Therapies 2
-
- Microtubule and mitosis dynamics 2
- Co-authors
- Denis DryginWilliam G. RiceAdam Siddiqui-JainKenna AnderesChris ProffittSean O’BrienDavid M. RyckmanNicole Streiner
- Cited by
- Molecular BiologyOncologyGenetics
- Partner nations
- United StatesAustralia
In The Last Decade
Nanni Huser
15 papers receiving 983 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 737
- Oncology 238
- Genetics 82
- Hematology 68
- Cancer Research 84
Countries citing papers authored by Nanni Huser
This map shows the geographic impact of Nanni Huser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanni Huser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanni Huser more than expected).
Fields of papers citing papers by Nanni Huser
This network shows the impact of papers produced by Nanni Huser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanni Huser. The network helps show where Nanni Huser may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nanni Huser, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 6 | |
| 3 | 2017 | 49 | |
| 4 | 2017 | 95 | |
| 5 | 2017 | 16 | |
| 6 | 2012 | 86 | |
| 7 | 2012 | 59 | |
| 8 | 2012 | 114 | |
| 9 | 2011 | 4 | |
| 10 | 2011 | 1 | |
| 11 | 2010 | 421 | |
| 12 | 2010 | 3 | |
| 13 | 2009 | 140 | |
| 14 | 2009 | 1 | |
| 15 | In vitro and in vivo antitumor activities of SGX523, a novel MET inhibitor | 2007 | 3 |
About Nanni Huser
Nanni Huser is a scholar working on Oncology, Hematology and Molecular Biology, having authored 15 papers that have together received 999 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (5 papers), Cancer-related Molecular Pathways (4 papers), Advanced Breast Cancer Therapies (2 papers), Acute Myeloid Leukemia Research (2 papers), DNA Repair Mechanisms (2 papers), RNA modifications and cancer (2 papers), HER2/EGFR in Cancer Research (2 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Molecular Biology (737 citations), Oncology (238 citations) and Genetics (82 citations). Nanni Huser has collaborated with scholars based in United States and Australia. Frequent co-authors include Denis Drygin, William G. Rice, Adam Siddiqui-Jain, Kenna Anderes, Chris Proffitt, Sean O’Brien, David M. Ryckman, Nicole Streiner, Caroline B. Ho and Mayuko Omori. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Neoplasia, ACS Medicinal Chemistry Letters and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.